Rockville, MD, United States of America

Hatice Karauzum

USPTO Granted Patents = 5 

 

 

Average Co-Inventor Count = 5.6

ph-index = 1

Forward Citations = 8(Granted Patents)


Location History:

  • Silver Spring, MD (US) (2015 - 2018)
  • Rockville, MD (US) (2017 - 2022)

Company Filing History:


Years Active: 2015-2022

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Hatice Karauzum: Innovator in Immunogenic Compositions

Introduction

Hatice Karauzum is a prominent inventor based in Rockville, MD (US). She has made significant contributions to the field of immunology, particularly in the development of immunogenic compositions for the prevention and treatment of infections. With a total of 5 patents to her name, her work is paving the way for advancements in medical treatments.

Latest Patents

Her latest patents include innovative compositions that provide methods for inducing an immune response against LukAB-expressing infections. These patents detail the use of toxoid peptides derived from phenol soluble modulin, delta toxin, superantigens, and their fusions. The disclosures emphasize the importance of multivalent oligopeptides and fusion proteins that comprise various staphylococcal proteins, which can be crucial in combating infections.

Career Highlights

Throughout her career, Hatice has worked with notable companies such as Integrated Biotherapeutics, Inc. and Integrated Biotherapeutic Vaccines, Inc. Her expertise in immunogenic compositions has positioned her as a key player in the biotherapeutics industry.

Collaborations

She has collaborated with esteemed colleagues, including Mohammad Javad Aman and Rajan Prasad Adhikari, further enhancing her research and development efforts in the field.

Conclusion

Hatice Karauzum's innovative work in immunogenic compositions showcases her dedication to advancing medical science. Her contributions are vital in the ongoing fight against infections, and her patents reflect her commitment to improving health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…